Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.

Open	$53.56
Close	$52.45
Volume / Avg.	940.11K / 448.90K
Day Range	$52.05 - $54.23
52 Wk Range	23.14 - 53.76
Market Cap	$2.52B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	15.9%
Days to Cover	12.37

Recent News

FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol

Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

Vandana Singh

Is First Trust Small Cap Growth AlphaDEX ETF a Strong ETF Right Now?

Launched on 04/19/2011, the First Trust Small Cap Growth AlphaDEX ETF (NASDAQ: FYC) is a smart beta exchange traded fund offering broad exposure to the Style Box - Small Cap Growth category of the market.

Zacks

Should First Trust Small Cap Growth AlphaDEX ETF Be on Your Investing Radar?

Launched on 04/19/2011, the First Trust Small Cap Growth AlphaDEX ETF (NASDAQ: FYC) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Growth segment of the US equity market.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$53.56
Close	$52.45
Volume / Avg.	940.11K / 448.90K
Day Range	$52.05 - $54.23
52 Wk Range	23.14 - 53.76
Market Cap	$2.52B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	15.9%
Days to Cover	12.37

About Mirum Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mirum Pharmaceuticals (MIRM) stock?

You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.

View our list of the best stock brokerages

Who are Mirum Pharmaceuticals (MIRM) competitors?

Other companies in Mirum Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Mirum Pharmaceuticals (MIRM) stock?

Mirum Pharmaceuticals has a consensus price target of $55.87.

What is the current price for Mirum Pharmaceuticals (MIRM)?

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $52.45 last updated February 21, 2025 at 4:26 PM EST.

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

There are no upcoming dividends for Mirum Pharmaceuticals.

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

Mirum Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Mirum Pharmaceuticals (MIRM) going to split?

There is no upcoming split for Mirum Pharmaceuticals.

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Mirum Pharmaceuticals

Mirum Pharmaceuticals (MIRM) Forecast